Literature DB >> 10592955

Ethylene glycol exposures managed by the ASPCA National Animal Poison Control Center from July 1995 to December 1997.

S A Khan1, M M Schell, H L Trammel, S R Hansen, M W Knight.   

Abstract

Five-hundred and ten cases of ethylene glycol (EG) exposures in animals were compiled by the ASPCA National Animal Poison Control Center from July 1995 through December 1997. Case distribution was analyzed by species, sex, age, weight, seasonality, treatment intervention and final outcome. Dogs and cats were most commonly involved (98.0%). The sex distribution was approximately equal. Adult animals accounted for the majority of cases. Exposures were commonly (57.0%) from container spill, engine flush, or engine leak and were in or around the home (66.0%). Cases were reported throughout the year with slight increase during March-May. Among cases with a known final outcome, 59.0% did not show clinical signs and death/euthanasia, major and minor illness was reported in 28.0%, 5.0% and 8.0%. In view of the widespread use and potential toxicity of EG, the low number of EG exposures reported (510) among the total number of hazardous exposures (97,383) to all substances for the same period was remarkable. The EG exposures resulting in animal death/euthanasia were lower than previously published.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10592955

Source DB:  PubMed          Journal:  Vet Hum Toxicol        ISSN: 0145-6296


  2 in total

1.  Ethylene glycol toxicosis in adult beef cattle fed contaminated feeds.

Authors:  Robert Barigye; Michelle Mostrom; Neil W Dyer; Teresa K Newell; Gregory P Lardy
Journal:  Can Vet J       Date:  2008-10       Impact factor: 1.008

2.  Ethylene glycol: Evidence of glucuronidation in vivo shown by analysis of clinical toxicology samples.

Authors:  Daniel Sejer Pedersen; Patrick Bélanger; Mikael Frykman; Kirsten Andreasen; Danielle Goudreault; Henrik Pedersen; Peter Hindersson; Torben Breindahl
Journal:  Drug Test Anal       Date:  2019-04-17       Impact factor: 3.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.